Free Trial

Roivant Sciences (ROIV) Insider Trading & Ownership

Roivant Sciences logo
$39.53 -0.46 (-1.15%)
Closing price 11/13/2026 04:00 PM Eastern
Extended Trading
$39.68 +0.16 (+0.39%)
As of 11/13/2026 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Roivant Sciences (NASDAQ:ROIV) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
8.80%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
9
Amount Of
Insider Selling
(Last 12 Months)
$558.76M
Get ROIV Insider Trade Alerts

Want to know when executives and insiders are buying or selling Roivant Sciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ROIV Insider Buying and Selling by Quarter

Roivant Sciences Insider and Congressional Trades History

Transaction Date
0 Results
Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/11/2026Sell175,000$41.85$7,323,750.00  
11/10/2026Sell187,943$40.53$7,617,329.79  
11/10/2026Sell125,000$41.20$5,150,000.00  
11/3/2026Sell200,000$36.31$7,262,000.00  
10/28/2026Sell200,000$36.59$7,318,000.00  
10/20/2026Sell200,000$35.11$7,022,000.00  
10/1/2026Sell17,750$36.10$640,775.00  
9/30/2026Sell200,000$36.62$7,324,000.00  
9/15/2026Sell4,938$39.74$196,236.12  
8/28/2026Sell200,000$35.77$7,154,000.00  
8/21/2026Sell144,756$36.48$5,280,698.88  
8/20/2026Sell17,519$37.30$653,458.70  
8/19/2026Sell172,899$37.17$6,426,655.83  
8/18/2026Sell136,942$36.73$5,029,879.66  
8/17/2026Sell284,707$36.25$10,320,628.75  
8/14/2026Sell243,177$36.23$8,810,302.71  
7/27/2026Sell200,000$34.95$6,990,000.00  
6/30/2026Sell12,380$35.28$436,766.40  
6/29/2026Sell800,000$34.55$27,640,000.00  
6/29/2026Sell17,750$34.38$610,245.00  
6/26/2026Sell625,783$34.00$21,276,622.00  
6/24/2026Sell200,000$33.16$6,632,000.00  
5/22/2026Sell200,000$30.27$6,054,000.00  
4/20/2026Sell200,000$29.59$5,918,000.00  
4/16/2026Sell289,774$29.16$8,449,809.84  
4/8/2026Sell13,538$28.37$384,073.06  
3/17/2026Sell200,000$28.24$5,648,000.00  
3/16/2026Sell41,861$28.68$1,200,573.48  
2/23/2026Sell587,390$27.51$16,159,098.90  
2/20/2026Sell1,012,610$27.15$27,492,361.50  
2/19/2026Sell1,400,000$27.42$38,388,000.00  
2/13/2026Sell375,784$26.50$9,958,276.00  
2/13/2026Sell200,000$26.49$5,298,000.00  
2/11/2026Sell425,000$26.67$11,334,750.00  
2/9/2026Sell339,441$26.47$8,985,003.27  
1/12/2026Sell200,000$21.92$4,384,000.00  
12/31/2025Sell1,018,995$21.71$22,122,381.45  
12/29/2025Sell311,873$21.74$6,780,119.02  
12/24/2025Sell75,000$22.53$1,689,750.00  
12/23/2025Sell200,000$22.45$4,490,000.00  
Management just bought 2.8 million shares (Ad)

Management just backed a $100 million buyback, repurchasing 2.8 million shares at an average price of $35.26 in one quarter. Institutions own about 83% of shares, including BlackRock's 32 million shares worth $716 million and Vanguard's 48 million shares worth nearly $1.1 billion. A new multi-year deal with Palantir adds an AI-driven edge to this energy producer's operations.tc pixel

Watch the briefing on this buyback and AI opportunity now
12/23/2025Sell406,731$22.43$9,122,976.33  
12/17/2025Sell777,332$23.07$17,933,049.24  
12/17/2025Sell26,831$23.09$619,527.79  
12/16/2025Sell917,282$23.04$21,134,177.28  
12/15/2025Sell1,740,000$21.68$37,723,200.00  
12/15/2025
Vivek Ramaswamy
Major Shareholder
Sell353,745$22.05$7,800,077.25  
12/12/2025
Vivek Ramaswamy
Major Shareholder
Sell1,975,858$21.96$43,389,841.68  
12/11/2025
Vivek Ramaswamy
Major Shareholder
Sell774,142$21.64$16,752,432.88  
12/9/2025Sell200,000$20.85$4,170,000.00  
11/19/2025Sell1,300,000$20.23$26,299,000.00  
11/17/2025
Vivek Ramaswamy
Major Shareholder
Sell539,650$20.51$11,068,221.50  
11/14/2025
Vivek Ramaswamy
Major Shareholder
Sell1,027,670$20.33$20,892,531.10  
(Data available from 1/1/2013 forward)

ROIV Insider Trading Activity - Frequently Asked Questions

8.80% of Roivant Sciences stock is owned by insiders. Learn more on ROIV's insider holdings.

The following insiders have purchased ROIV shares in the last 24 months: Matthew Gline ($49,957.05), and Sciences Ltd. Roivant ($336,900,200.00).

Insiders have purchased a total of 16,848,325 ROIV shares in the last 24 months for a total of $336,950,157.05 bought.

The following insiders have sold ROIV shares in the last 24 months: Daniel Allen Gold ($136,012,640.92), Eric Venker ($187,653,824.74), Frank Torti ($82,039,460.40), Jennifer Humes ($384,073.06), Matthew Gline ($46,173,009.84), Mayukh Sukhatme ($90,512,480.21), Melissa B Epperly ($2,647,829.60), Rakhi Kumar ($2,372,825.00), Richard Pulik ($21,596,726.33), and Vivek Ramaswamy ($153,019,587.21).

Insiders have sold a total of 34,015,924 Roivant Sciences shares in the last 24 months for a total of $722,412,457.31 sold.



Insider trading data for NASDAQ:ROIV was last updated on 11/11/2026, the date of the most recent reported insider or congressional trade. New trades are added as they're reported.
From Our Partners